Sam Backenroth

2017 - Ohr Pharmaceutical

In 2017, Sam Backenroth earned a total compensation of $216.7K as Chief Financial Officer at Ohr Pharmaceutical, a 76% decrease compared to previous year.

Compensation breakdown

Salary$200,000
Other$16,729
Total$216,729

Backenroth received $200K in salary, accounting for 92% of the total pay in 2017.

Backenroth also received $16.7K in other compensation.

Rankings

In 2017, Sam Backenroth's compensation ranked 13,928th out of 14,666 executives tracked by ExecPay. In other words, Backenroth earned more than 5.0% of executives.

ClassificationRankingPercentile
All
13,928
out of 14,666
5th
Division
Manufacturing
5,462
out of 5,768
5th
Major group
Chemicals And Allied Products
1,961
out of 2,074
5th
Industry group
Drugs
1,634
out of 1,730
6th
Industry
Pharmaceutical Preparations
1,250
out of 1,329
6th
Source: SEC filing on September 7, 2018.

Backenroth's colleagues

We found two more compensation records of executives who worked with Sam Backenroth at Ohr Pharmaceutical in 2017.

2017

Avner Ingerman

Ohr Pharmaceutical

Former Chief Clinical Officer

2017

Jason Slakter

Ohr Pharmaceutical

Chief Executive Officer

News

You may also like